Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2018 2
2019 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO, Li D, Verret W, Xu DZ, Hernandez S, Liu J, Huang C, Mulla S, Wang Y, Lim HY, Zhu AX, Cheng AL; IMbrave150 Investigators. Finn RS, et al. N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745. N Engl J Med. 2020. PMID: 32402160 Clinical Trial.
Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells.
Asghari V, Wang JF, Reiach JS, Young LT. Asghari V, et al. Brain Res Mol Brain Res. 1998 Jul 15;58(1-2):95-102. doi: 10.1016/s0169-328x(98)00107-7. Brain Res Mol Brain Res. 1998. PMID: 9685595
In the present study, we report differential effects of the two most commonly prescribed mood stabilizers used to treat BD on Fos/Jun protein levels and their AP-1 binding activity in human neuroblastoma SH-SY5Y cells. At therapeutically relevant concentrations, both drugs …
In the present study, we report differential effects of the two most commonly prescribed mood stabilizers used to treat BD on Fos/Jun protei …
Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells.
Wang JF, Asghari V, Rockel C, Young LT. Wang JF, et al. Neuroscience. 1999;91(2):771-6. doi: 10.1016/s0306-4522(98)00627-7. Neuroscience. 1999. PMID: 10366032
We report here that chronic, but not acute treatment with lithium chloride in human neuroblastoma SH-SY5Y cells, inhibits phosphorylation of cyclic AMP responsive element binding protein and cyclic AMP responsive element DNA binding induced by the adenylyl cyclase activato …
We report here that chronic, but not acute treatment with lithium chloride in human neuroblastoma SH-SY5Y cells, inhibits phosphoryla …
Trigonella foenum-graceum seed (Fenugreek) hydroalcoholic extract improved the oxidative stress status in a rat model of diabetes-induced memory impairment.
Bafadam S, Beheshti F, Khodabakhshi T, Asghari A, Ebrahimi B, Sadeghnia HR, Mahmoudabady M, Niazmand S, Hosseini M. Bafadam S, et al. Horm Mol Biol Clin Investig. 2019 Jun 6;39(2):/j/hmbci.2019.39.issue-2/hmbci-2018-0074/hmbci-2018-0074.xml. doi: 10.1515/hmbci-2018-0074. Horm Mol Biol Clin Investig. 2019. PMID: 31188777
After the passive avoidance test, malondialdehyde (MDA), nitric oxide (NO) metabolites, total thiol (SH), catalase (CAT) and superoxide dismutase (SOD) were determined in the brain. ...
After the passive avoidance test, malondialdehyde (MDA), nitric oxide (NO) metabolites, total thiol (SH), catalase (CAT) and superoxi …
Cochlear implantation in children with auditory neuropathy spectrum disorder: A multicenter study on auditory performance and speech production outcomes.
Daneshi A, Mirsalehi M, Hashemi SB, Ajalloueyan M, Rajati M, Ghasemi MM, Emamdjomeh H, Asghari A, Mohammadi S, Mohseni M, Mohebbi S, Farhadi M. Daneshi A, et al. Int J Pediatr Otorhinolaryngol. 2018 May;108:12-16. doi: 10.1016/j.ijporl.2018.02.004. Epub 2018 Feb 7. Int J Pediatr Otorhinolaryngol. 2018. PMID: 29605339